InterMune: Clinical Trials

23 trials sponsored by InterMune, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

15 completed, 6 terminated, 2 unknown. 13 Phase 2, 6 Phase 3, 3 Phase 1, 2 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 213Completed 10, Terminated 2, Unknown 1
Phase 36Terminated 4, Completed 2
Phase 13Completed 2, Terminated 1
Phase 42Completed 2

Follow InterMune: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Modelling of Quality Life, Clinical and Physiological Measures in Idiopathic Pulmonary Fibrosis
Idiopathic Pulmonary Fibrosis, Dyspnoea
UnknownUniversity of East Anglia2502014-06-012016-06-13
A Phase II Study to Determine the Safety and Efficacy of Interferon-gamma in Patients With Chronic Hepatitis B
IFN-γ 1b (Actimmune), Adefovir dipivoxil, IFN-γ 1b and Adefovir dipivoxil combination - Hepatitis B
Phase 2UnknownHuntington Medical Research Institutes302008-09-012010-10-21
Study of Gamma Interfereon in Metastatic Colorectal Carcinoma
5-Fluorouracil, Leucovorin (LV), Gamma-Interferon-1b (IFN-γ) - Colorectal Cancer
Phase 2CompletedAccelerated Community Oncology Research Network482006-02-012012-03-01
Study of High Dosage CIFN Plus RBV for HCV Genotype 1 Infected Patients Who Are Nonresponders to Prior Therapy
Interferon Alfacon-1 and Ribavirin - Hepatitis C
Phase 4CompletedBeth Israel Medical Center402005-12-012008-04-17
Infergen, Ribavirin & Avandia in Previous Relapsers or Nonresponders to Pegylated Interferon and Ribavirin
rosiglitazone - Hepatitis C
Phase 4CompletedBrooke Army Medical Center342005-10-012012-02-14
Hepatitis C Treatment Naive Genotype 1 Consensus Interferon Trial
consensus interferon (Interferon Alfacon-1) and ribavirin, Consensus Interferon alfa (CIFN) and ribavirin - Chronic Hepatitis C
Phase 3CompletedMinneapolis Veterans Affairs Medical Center642005-07-012014-11-21
Interferon Gamma With Peg-Interferon Alpha 2a and Ribavirin in Non Responders Patients With Chronic Hepatitis C
Peg-interferon alpha 2a (drug), Ribavirin (drug), Interferon gamma (drug) - Hepatitis C, Chronic
Phase 2CompletedFrench National Agency for Research on AIDS and Viral Hepatitis652004-06-012007-08-30
CIFN and IFN γ-1b With or Without Ribavirin for Treatment of Chronic Hepatitis C (Nonresponders)
Consensus Interferon-Alpha, Interferon Gamma-1b, Ribavirin - Chronic Hepatitis C
Phase 2CompletedInterMune812004-04-012009-07-03
The INSPIRE Trial: A Study of Interferon Gamma-1b for Idiopathic Pulmonary Fibrosis (IPF)
Interferon gamma-1b ("Actimmune") - Idiopathic Pulmonary Fibrosis, Lung Disease
Phase 3TerminatedInterMune8262003-12-012009-07-02
An Open-Label Study of the Safety of Interferon Gamma-1b in Patients With IPF
Interferon gamma-1b - Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis
Phase 3TerminatedInterMune912003-11-012007-11-06
Safety of Interferon Gamma-1b With Rituximab in Non-Hodgkin's Lymphoma Patients
Interferon Gamma-1b, Rituximab - Non-Hodgkin's Lymphoma
Phase 1 / Phase 2TerminatedInterMune242003-03-012007-11-01
Chemoimmunotherapy Study for Patients With Epithelial Ovarian Cancer
Carboplatin, GM-CSF (Sargramostim), Interferon Gamma - Ovarian Cancer, Fallopian Tube Cancer
Phase 2CompletedM.D. Anderson Cancer Center592003-01-012012-08-07
An Open-Label Study of the Safety and Efficacy of Subcutaneous Recombinant Interferon-Gamma 1b (IFN-Gamma 1b) in Patients With Idiopathic Pulmonary Fibrosis (IPF)
interferon-gamma 1b - Lung Disease, Pulmonary Fibrosis
Phase 2CompletedInterMune2102002-09-012007-11-06
A Randomized, Double-Blind, Three-Arm, Phase 3b Study Comparing the Safety and Efficacy of Interferon Gamma-1b With Azathioprine, and Azathioprine Alone in Patients With IPF Receiving Prednisone
interferon-gamma 1b, azathioprine - Lung Disease, Pulmonary Fibrosis
Phase 3TerminatedInterMune2002-04-012007-11-06
Study of Interferon Gamma-1b by Injection for the Treatment of Patients With Cystic Fibrosis
interferon gamma-1b - Cystic Fibrosis
Phase 1 / Phase 2CompletedInterMune512002-04-012007-11-01
Post Marketing Surveillance Study of Actimmune in Patients With Severe, Malignant Osteopetrosis
Actimmune Registry - Osteopetrosis
CompletedInterMune62002-01-012007-11-01
A Study of the Safety and Clinical Effects of Interferon Gamma-1b in Patients With Idiopathic Pulmonary Fibrosis (IPF)
Interferon-gamma 1b - Idiopathic Pulmonary Fibrosis
Phase 2CompletedInterMune322001-11-012007-11-06
Safety and Efficacy of Interferon Gamma-1b Plus Chemotherapy for Ovarian and Peritoneal Cancer
Interferon gamma-1b - Ovarian Carcinoma, Peritoneal Carcinoma
Phase 3TerminatedInterMune8472001-10-012007-11-01
Safety and Efficacy Study of Interferon Gamma-1b in Hepatitis C Patients With Liver Fibrosis or Cirrhosis
interferon gamma-1b - Liver Fibrosis, Cirrhosis
Phase 2CompletedInterMune5022001-09-012007-11-01
Interferon Gamma-1b by Inhalation for the Treatment of Patients With Cystic Fibrosis
interferon gamma-1b - Cystic Fibrosis
Phase 1 / Phase 2CompletedInterMune662001-02-012007-11-01

Showing 20 of 23. Sign in to see all of them.

Conditions studied

Idiopathic Pulmonary Fibrosis (7)  ·  Hepatitis C (4)  ·  Lung Diseases (4)  ·  Pulmonary Fibrosis (4)  ·  Fibrosis (3)  ·  Hepatitis C, Chronic (3)  ·  Cystic Fibrosis (2)  ·  Ovarian Neoplasms (2)  ·  Anxiety Disorders (1)  ·  Carcinoma (1)  ·  Colorectal Neoplasms (1)  ·  Depression (1)  ·  Dyspnea (1)  ·  Fallopian Tube Neoplasms (1)  ·  HIV Infections (1)

Interventions

interferon gamma-1b (12)  ·  Interferon-gamma (8)  ·  Ribavirin (5)  ·  interferon alfacon-1 (3)  ·  Amphotericin B (1)  ·  Azathioprine (1)  ·  Bevacizumab (1)  ·  Carboplatin (1)  ·  Fluconazole (1)  ·  Flucytosine (1)  ·  Fluorouracil (1)  ·  Granulocyte-Macrophage Colony-Stimulating Factor (1)  ·  Itraconazole (1)  ·  Leucovorin (1)  ·  Pharmaceutical Preparations (1)

Countries

United States (16)  ·  France (1)  ·  Italy (1)  ·  Peru (1)  ·  United Kingdom (1)

Top investigators

Steven Porter, MD (5)  ·  Javier Szwarcberg, MD (2)  ·  Williamson Bradford, MD (2)  ·  Andrew M Wilson (1)  ·  Henry C. Bodenheimer, M.D. (1)  ·  Lee Schwartzberg, MD (1)  ·  Matthew McClure, MD (1)  ·  Myron J Tong, Phd, MD (1)  ·  Patrice Couzigou, MD, PhD (1)  ·  Ralph Freedman, MD, PhD (1)  ·  Samuel B. Ho, M.D. (1)  ·  Shane Mills, MD (1)

Results publications

PMID 28657784, PMID 38238788, PMID 11984144, PMID 12375147, PMID 15191208, PMID 15940636, PMID 15994231, PMID 16912304, PMID 17030856, PMID 19264351, PMID 19570573, PMID 2106474, PMID 21221804, PMID 23190183, PMID 24311766, PMID 2452123, PMID 31047956, PMID 3129521, PMID 33434107, PMID 35688625

NIH funding

2004 (1)